Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 120-130

  Biver, Emmanuel ^a,b   Thouverey, Cyril ^a   Magne, David ^c   Caverzasio, Joseph ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Physiopathologie des Maladies Osseuses Inflammatoires   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Bone morphogenic proteins; Fibroblast growth factor; Mesenchymal stem cells; Osteoblastic differentiation; Platelet derived growth factor; Wnt catenin

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SMAD1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR OSTERIX;

ARTICLE; CALCIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ALP; BMPS; BONE MORPHOGENIC PROTEINS; BONE SIALOPROTEIN; BSP; C-JUN AMINO-TERMINAL KINASES; EGF; EPIDERMAL GROWTH FACTOR; ERK; EXTRACELLULAR SIGNAL REGULATED KINASES; FGF; FIBROBLAST GROWTH FACTOR; GLYCOGEN SYNTHASE KINASE 3; GSK3; HMSC; HUMAN MSC; JNK; MAPK; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED-PROTEIN KINASE; MSC; OSTEOBLASTIC DIFFERENTIATION; OSTERIX; OSX; PDGF; PLATELET DERIVED GROWTH FACTOR; RECEPTORS TYROSINE KINASE; RTK; TGF-Β; TRANSFORMING GROWTH FACTOR BETA; WNT/SS-CATENIN;

BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; OSTEOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITORS; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD PROTEINS; YOUNG ADULT;

EID: 84885115199     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.09.018     Document Type: Article

References (73)

1. Ahn H.J., Lee W.J., Kwack K., Kwon Y.D. FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett. 2009, 583:2922-2926.
2. Baron R., Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 2013, 19:179-192.
3. Berrada S., Lefebvre F., Harmand M.F. The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression. In Vitro Cell Dev. Biol. Anim. 1995, 31:698-702.
4. Bianco P., Robey P.G. Stem cells in tissue engineering. Nature 2001, 414:118-121.
5. Biver E., Soubrier A.S., Thouverey C., Cortet B., Broux O., Caverzasio J., Hardouin P. Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2012, 427:737-742.
6. Boland G.M., Perkins G., Hall D.J., Tuan R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem. 2004, 93:1210-1230.
7. Canalis E., Centrella M., McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 1988, 81:1572-1577.
8. Caplan A.I., Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J. Orthop. Res. 2011, 29:1795-1803.
9. Cárcamo-Orive I., Tejados N., Delgado J., Gaztelumendi A., Otaegui D., Lang V., Trigueros C. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp. Cell Res. 2008, 314:1777-1788.
10. Cárcamo-Orive I., Gaztelumendi A., Delgado J., Tejados N., Dorronsoro A., Fernández-Rueda J., Pennington D.J., Trigueros C. Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk. J. Bone Miner. Res. 2010, 25:2115-2125.
11. Caverzasio J., Palmer G., Suzuki A., Bonjour J.P. Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: evidences for a G protein-dependent tyrosine phosphorylation process. J. Bone Miner. Res. 1997, 12:1975-1983.
12. Chaudhary L.R., Hofmeister A.M., Hruska K.A. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004, 34:402-411.
13. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001, 2:769-776.
14. Devescovi V., Leonardi E., Ciapetti G., Cenni E. Growth factors in bone repair. Chir. Organi Mov. 2008, 92:161-168.
15. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 2003, 116:1175-1186.
16. Fakhry A., Ratisoontorn C., Vedhachalam C., Salhab I., Koyama E., Leboy P., Pacifici M., Kirschner R.E., Nah H.D. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 2005, 36:254-266.
17. Fang M.A., Glackin C.A., Sadhu A., McDougall S. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells. J. Cell. Biochem. 2001, 80:550-559.
18. Feres-Filho E.J., Menassa G.B., Trackman P.C. Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 1996, 271:6411-6416.
19. Frank O., Heim M., Jakob M., Barbero A., Schafer D., Bendik I., Dick W., Heberer M., Martin I. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 2002, 85:737-746.
20. Fredriksson L., Li H., Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004, 15:197-204.
21. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., De Robertis E.M. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-993.
22. Gambardella A., Nagaraju C.K., O'Shea P.J., Mohanty S.T., Kottam L., Pilling J., Sullivan M., Djerbi M., Koopmann W., Croucher P.I., Bellantuono I. Glycogen synthase kinase-3alpha/beta inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. J. Bone Miner. Res. 2011, 26:811-821.
23. Garcia-Gomez A., Ocio E.M., Crusoe E., Santamaria C., Hernandez-Campo P., Blanco J.F., Sanchez-Guijo F.M., Hernandez-Iglesias T., Brinon J.G., Fisac-Herrero R.M., Lee F.Y., Pandiella A., San Miguel J.F., Garayoa M. Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects. PLoS ONE 2012, 7:e34914.
24. Graham S., Leonidou A., Lester M., Heliotis M., Mantalaris A., Tsiridis E. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin. Inv. Drugs 2009, 18:1633-1654.
25. Graves D.T., Valentin-Opran A., Delgado R., Valente A.J., Mundy G., Piche J. The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells. Connect. Tissue Res. 1989, 23:209-218.
26. Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 2003, 18:2060-2068.
27. Hamdy R.C., Amako M., Beckman L., Kawaguchi M., Rauch F., Lauzier D., Steffen T. Effects of osteogenic protein-1 on distraction osteogenesis in rabbits. Bone 2003, 33:248-255.
28. Hughes-Fulford M., Li C.F. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J. Orthop. Surg. Res. 2011, 6:8.
29. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 1993, 268:5588-5593.
30. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64:295-312.
31. Kempen D.H., Creemers L.B., Alblas J., Lu L., Verbout A.J., Yaszemski M.J., Dhert W.J. Growth factor interactions in bone regeneration. Tissue Eng. Part B Rev. 2010, 16:551-566.
32. Kloen P., Lauzier D., Hamdy R.C. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions. Bone 2012, 51:59-68.
33. Kotev-Emeth S., Pitaru S., Pri-Chen S., Savion N. Establishment of a rat long-term culture expressing the osteogenic phenotype: dependence on dexamethasone and FGF-2. Connect. Tissue Res. 2002, 43:606-612.
34. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308:1472-1477.
35. Krattinger N., Applegate L.A., Biver E., Pioletti D.P., Caverzasio J. Regulation of proliferation and differentiation of human fetal bone cells. Eur. Cell Mater. 2011, 21:46-58.
36. Krause U., Harris S., Green A., Ylostalo J., Zeitouni S., Lee N., Gregory C.A. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc. Nat. Acad. Sci. USA 2010, 107:4147-4152.
37. Krebsbach P.H., Kuznetsov S.A., Bianco P., Robey P.G. Bone marrow stromal cells: characterization and clinical application. Crit. Rev. Oral. Biol. Med. 1999, 10:165-181.
38. Krejci P., Prochazkova J., Bryja V., Kozubik A., Wilcox W.R. Molecular pathology of the fibroblast growth factor family. Hum. Mutat. 2009, 30:1245-1255.
39. Kretzschmar M., Doody J., Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997, 389:618-622.
40. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., Rosen V., Stein J.L., van Wijnen A.J., Stein G.S., Lian J.B., Ryoo H.M. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell. Biochem. 1999, 73:114-125.
41. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M., Bae S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 2000, 20:8783-8792.
42. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 2003, 278:34387-34394.
43. Lin G.L., Hankenson K.D. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J. Cell. Biochem. 2011, 112:3491-3501.
44. Ling L., Murali S., Dombrowski C., Haupt L.M., Stein G.S., van Wijnen A.J., Nurcombe V., Cool S.M. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J. Cell. Physiol. 2006, 209:811-825.
45. Lowery J.W., Pazin D., Intini G., Kokabu S., Chappuis V., Capelo L.P., Rosen V. The role of BMP2 signaling in the skeleton. Crit. Rev. Eukaryot. Gene. Expr. 2011, 21:177-185.
46. Lowry O.H., Roberts N.R., Wu M.L., Hixon W.S., Crawford E.J. The quantitative histochemistry of brain. II. Enzyme measurements. J. Biol. Chem. 1954, 207:19-37.
47. Maegawa N., Kawamura K., Hirose M., Yajima H., Takakura Y., Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J. Tissue Eng. Regen. Med. 2007, 1:306-313.
48. Marie, P.J., Miraoui, H., Severe, N., 2012. FGF/FGFR signaling in bone formation: progress and perspectives. Growth factors (Chur, Switzerland) 30, 117-123.
49. Marsell R., Sisask G., Nilsson Y., Sundgren-Andersson A.K., Andersson U., Larsson S., Nilsson O., Ljunggren O., Jonsson K.B. GSK-3 inhibition by an orally active small molecule increases bone mass in rats. Bone 2012, 50:619-627.
50. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
51. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp. Biol. Med. (Maywood) 2001, 226:507-520.
52. Miraoui H., Oudina K., Petite H., Tanimoto Y., Moriyama K., Marie P.J. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J. Biol. Chem. 2009, 284:4897-4904.
53. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999, 25:91-93.
54. Moore D.C., Ehrlich M.G., McAllister S.C., Machan J.T., Hart C.E., Voigt C., Lesieur-Brooks A.M., Weber E.W. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J. Bone Joint Surg. Am. 2009, 91:1973-1984.
55. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
56. Nakayama K., Tamura Y., Suzawa M., Harada S., Fukumoto S., Kato M., Miyazono K., Rodan G.A., Takeuchi Y., Fujita T. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J. Bone Miner. Res. 2003, 18:827-835.
57. Nauth A., Ristiniemi J., McKee M.D., Schemitsch E.H. Bone morphogenetic proteins in open fractures: past, present, and future. Injury 2009, 40(Suppl. 3). pp. S27-31.
58. Nauth A., Giannoudis P.V., Einhorn T.A., Hankenson K.D., Friedlaender G.E., Li R., Schemitsch E.H. Growth factors: beyond bone morphogenetic proteins. J. Orthop. Trauma 2010, 24:543-546.
59. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., Choong C., Yang Z., Vemuri M.C., Rao M.S., Tanavde V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008, 112:295-307.
60. Nishimura R., Hata K., Ikeda F., Ichida F., Shimoyama A., Matsubara T., Wada M., Amano K., Yoneda T. Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J. Bone Miner. Metab. 2008, 26:203-212.
61. Reigstad L.J., Varhaug J.E., Lillehaug J.R. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. 2005, 272:5723-5741.
62. Rodan S.B., Wesolowski G., Yoon K., Rodan G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 1989, 264:19934-19941.
63. Sapkota G., Alarcon C., Spagnoli F.M., Brivanlou A.H., Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell. 2007, 25:441-454.
64. Schwarz F., Sager M., Ferrari D., Mihatovic I., Becker J. Influence of recombinant human platelet-derived growth factor on lateral ridge augmentation using biphasic calcium phosphate and guided bone regeneration: a histomorphometric study in dogs. J. Periodontol. 2009, 80:1315-1323.
65. Seib F.P., Franke M., Jing D., Werner C., Bornhäuser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur. J. Cell Biol. 2009, 88:257-271.
66. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
67. Suzuki A., Guicheux J., Palmer G., Miura Y., Oiso Y., Bonjour J.P., Caverzasio J. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 2002, 30:91-98.
68. Tokunaga A., Oya T., Ishii Y., Motomura H., Nakamura C., Ishizawa S., Fujimori T., Nabeshima Y., Umezawa A., Kanamori M., Kimura T., Sasahara M. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J. Bone Miner. Res. 2008, 23:1519-1528.
69. Vaccaro A.R., Whang P.G., Patel T., Phillips F.M., Anderson D.G., Albert T.J., Hilibrand A.S., Brower R.S., Kurd M.F., Appannagari A., Patel M., Fischgrund J.S. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J. 2008, 8:457-465.
70. Wang W., Kirsch T. Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization. J. Cell Biol. 2002, 157:1061-1069.
71. Wang C.C., Cirit M., Haugh J.M. PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk. Mol. Syst. Biol. 2009, 5:246.
72. Wu D., Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 2010, 35:161-168.
73. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M., Rosen V., Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 1996, 220:366-371.